An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence after liver transplantation

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

246

HTML

1698

Tables (1-2)

127

Sum=2071

Jul 27, 2011 (publication date) through Apr 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Hepatol. Jul 27, 2011; 3(7): 198-204
Published online Jul 27, 2011. doi: 10.4254/wjh.v3.i7.198

Table 1 Baseline characteristics (n = 30)

Characteristics	Value
Gender (M:F), n	23:07
Age (years), median (range)	56 (38-70)
Genotype 1, n (%)	23 (77)
Overweight, n (%)	22 (73)
Diabetes Mellitus, n (%)	18 (60)
Months from Liver Transplant, median (range)	40.5 (2-132)
High HCV RNA, n (%)	17 (57)
Cirrhosis, n (%)	3 (10)

M: Male; F: Female. Overweight: Body mass index > 25 kg/m²; High HCV RNA > 800 000 IU/mL.

Citation: Hashemi N, Araya V, Tufail K, Thummalakunta L, Feyssa E, Azhar A, Niazi M, Ortiz J. An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence after liver transplantation. World J Hepatol 2011; 3(7): 198-204
URL: https://www.wjgnet.com/1948-5182/full/v3/i7/198.htm
DOI: https://dx.doi.org/10.4254/wjh.v3.i7.198